Skip to main content
Home

Simple CT metric predicts treatment-induced kidney impairment in prostate cancer patients

Damaged Organ

Though effective, Lu-177 radioligland therapy is not without side effects, some of which can be severe.

  • Read more about Simple CT metric predicts treatment-induced kidney impairment in prostate cancer patients

FTC inquiry pauses $615M healthcare staffing merger

Federal Trade Comission FTC Sign logo

Source

iStock

The merger between Aya Healthcare and Cross Country Healthcare was finalized in December 2024 and was expected to close in the first half of this year. It's unclear what information the Federal Trade Commission requested from both companies. 

  • Read more about FTC inquiry pauses $615M healthcare staffing merger

UVA Health CEO steps down following internal investigation

Resigned | Fired

Craig Kent served in his role for five years and resigned on Tuesday after an investigation into patient safety and hiring concerns followed employees signing a letter of no confidence.

  • Read more about UVA Health CEO steps down following internal investigation

Primary care is primed for AI. But is AI aligned with primary care?

primary care provider clinician physician doctor

Fewer than one-third of primary care clinicians have a say in selecting the AI products their institutions expect them to fold into their clinical workflows. That’s a problem. 

  • Read more about Primary care is primed for AI. But is AI aligned with primary care?

5 steps for evaluating radiology AI applications

Jason Poff, MD, director of innovation deployment for artificial intelligence (AI) at RadPartners, explains the five-step process he uses to evaluate medical imaging AI.

Jason Poff, MD, director of innovation deployment for artificial intelligence at Radiology Partners, explains the process he uses to evaluate medical imaging AI. 
 

  • Read more about 5 steps for evaluating radiology AI applications

FDA sued over ‘reckless and arbitrary’ semaglutide decision

The Outsourcing Facilities Association, a Texas-based trade group, is alleging that supply issues still remain for Ozempic and Wegovy. The group believes the FDA has ignored those issues.

  • Read more about FDA sued over ‘reckless and arbitrary’ semaglutide decision

Teleflex to acquire Biotronik’s vascular intervention business for $791M, split into 2 separate entities

Business newspaper

The acquisition helps Teleflex expand its interventional and vascular portfolios. Biotronik, meanwhile, is shifting its focus toward implantable devices and digital healthcare. 

  • Read more about Teleflex to acquire Biotronik’s vascular intervention business for $791M, split into 2 separate entities

Adaptable AI system detects subtle changes in imaging, has potential across multiple clinical settings

AI detects subtle changes in images over time.

The Learning-based Inference of Longitudinal imAge Changes, or LILAC, system harnesses machine learning to review medical images that have been collected over a prolonged period.

  • Read more about Adaptable AI system detects subtle changes in imaging, has potential across multiple clinical settings

FDA clears Google smartwatch tech that calls 911 when a user’s heart stops

Google has received U.S. Food and Drug Administration (FDA) for Loss of Pulse Detection, a new smartwatch feature that detects when a person’s heart stops beating and then automatically alerts emergency services. Good Pixel Smartwatch Loss of Pulse.

Image courtesy of Google.

Google worked with AI specialists, cardiologists and even stunt performers to develop its new smartwatch feature.

  • Read more about FDA clears Google smartwatch tech that calls 911 when a user’s heart stops

Popular TAVR valves linked to comparable long-term outcomes

The Medtronic CoreValve Evolut and the Edwards Lifesciences Sapien 3 TAVR valves.

An Evolut TAVR valve from Medtronic (left) and a Sapien 3 TAVR valve from Edwards Lifesciences (right).

Second-generation TAVR valves from Medtronic, Edwards Lifesciences and Boston Scientific are all associated with similar seven-year outcomes, according to a new retrospective study out of Italy. 

  • Read more about Popular TAVR valves linked to comparable long-term outcomes

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …368
    • Page 369
    • Page 370
    • Page 371
    • Current page 372
    • Page 373
    • Page 374
    • Page 375
    • Page 376 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme